CD4+ T cells may play an important role in peripheral immune interactions leading to MS, while CD8+ T cells are the predominant T-cell population in brain lesions in patients with MS, and the number of CD8+ T cells is most correlated with the degree of axonal damage (Bar-Or and Li, 2021). The gene discussed is CD8A; the disease is myeloid sarcoma.